State Street Corp Has $19.26 Million Stock Position in LifeStance Health Group, Inc. (NASDAQ:LFST)

State Street Corp increased its stake in shares of LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) by 4.7% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,750,656 shares of the company's stock after buying an additional 122,844 shares during the period. State Street Corp owned 0.72% of LifeStance Health Group worth $19,255,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Principal Financial Group Inc. boosted its stake in shares of LifeStance Health Group by 6.1% in the 3rd quarter. Principal Financial Group Inc. now owns 4,116,766 shares of the company's stock valued at $28,817,000 after purchasing an additional 235,316 shares during the last quarter. Jennison Associates LLC boosted its stake in LifeStance Health Group by 9.5% in the third quarter. Jennison Associates LLC now owns 2,136,942 shares of the company's stock valued at $14,959,000 after acquiring an additional 184,896 shares during the last quarter. Charles Schwab Investment Management Inc. grew its holdings in LifeStance Health Group by 36.9% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,104,453 shares of the company's stock worth $7,731,000 after acquiring an additional 297,723 shares during the period. Point72 Asset Management L.P. raised its position in shares of LifeStance Health Group by 24.9% during the 3rd quarter. Point72 Asset Management L.P. now owns 1,100,441 shares of the company's stock valued at $7,703,000 after acquiring an additional 219,329 shares during the last quarter. Finally, Dimensional Fund Advisors LP grew its stake in shares of LifeStance Health Group by 82.0% during the second quarter. Dimensional Fund Advisors LP now owns 1,016,452 shares of the company's stock worth $4,991,000 after purchasing an additional 457,930 shares during the period. Institutional investors and hedge funds own 85.50% of the company's stock.

Analyst Ratings Changes

LFST has been the subject of a number of analyst reports. The Goldman Sachs Group upgraded shares of LifeStance Health Group from a "neutral" rating to a "buy" rating and set a $10.00 price objective for the company in a report on Monday, December 16th. Barclays upped their target price on LifeStance Health Group from $6.00 to $7.00 and gave the stock an "underweight" rating in a report on Monday, November 11th. One research analyst has rated the stock with a sell rating, one has given a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, LifeStance Health Group has a consensus rating of "Hold" and an average target price of $8.70.

Insider Buying and Selling

In other LifeStance Health Group news, Director Robert Bessler sold 75,000 shares of LifeStance Health Group stock in a transaction on Wednesday, November 27th. The stock was sold at an average price of $7.54, for a total value of $565,500.00. Following the completion of the transaction, the director now directly owns 1,424,447 shares of the company's stock, valued at $10,740,330.38. The trade was a 5.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 6.60% of the stock is currently owned by insiders.

LifeStance Health Group Stock Performance

LFST stock traded up $0.03 during midday trading on Tuesday, reaching $7.29. 377,670 shares of the company were exchanged, compared to its average volume of 1,520,983. LifeStance Health Group, Inc. has a one year low of $4.64 and a one year high of $9.20. The firm has a market capitalization of $2.79 billion, a price-to-earnings ratio of -28.04 and a beta of 1.28. The business has a 50-day moving average price of $7.22 and a two-hundred day moving average price of $6.40. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.32 and a quick ratio of 1.32.

LifeStance Health Group (NASDAQ:LFST - Get Free Report) last announced its quarterly earnings results on Thursday, November 7th. The company reported ($0.02) EPS for the quarter, beating analysts' consensus estimates of ($0.07) by $0.05. The business had revenue of $312.70 million for the quarter, compared to analyst estimates of $302.25 million. LifeStance Health Group had a negative net margin of 7.90% and a negative return on equity of 6.66%. LifeStance Health Group's quarterly revenue was up 18.9% on a year-over-year basis. During the same quarter in the prior year, the business earned ($0.17) EPS. Equities research analysts forecast that LifeStance Health Group, Inc. will post -0.2 EPS for the current year.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.